Balanced news tone
News Sentiment
ABSI sentiment intelligence
Absci Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-21.7% over one week, +11.9% over four weeks, trend active, and materially above fair value.
Absci (NASDAQ:ABSI) Stock Price Down 7.6% - Should You Sell?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 26 Jun 2026 08:06
- Source
- Simply Wall St.
ABSCI CORP (ABSI) Soars 36.0%: Is Further Upside Left in the Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source
United States - Goodwin Guides Absci On Pricing Of $100 Million Underwritten Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Mondaq
Absci raises $100M as Lilly joins investors backing AI drug program
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Investing.com
Absci (ABSI) Stock Rallies As Wall Street Boosts Targets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- timothysykes.com
Absci (NASDAQ: ABSI) prices $100M underwritten equity deal to fund ABS-201
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Form 424B5 Absci Corp For: 24 June By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Investing.com Canada
Absci’s ABS-201 shows 65-day half-life in alopecia trial
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Stock Titan
Absci rises after early-stage trial data for hair loss therapy and $100M stock offering
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Seeking Alpha
Guggenheim is Bullish on Absci Corporation (ABSI)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Market source
Absci Corp stock hits 52-week high at 8.18 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Investing.com
Is Absci Corporation (ABSI) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Jun 2026 07:00
- Source
- Market source
Guggenheim raises Absci stock price target to $15 on hair loss drug
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 15 Jun 2026 07:00
- Source
- Investing.com
Absci Corp (ABSI) awards RSUs and stock options to director Szela
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Absci Corp stock hits 52-week high at 7.44 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Investing.com
Absci Insiders Placed Bullish Bets Worth US$1.22m
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- simplywall.st
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Absci Corp (ABSI) director Menelas Pangalos adds 37,453 shares in open-market buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Stock Titan
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Absci (ABSI) posts Q1 2026 results, advances ABS-201 and adds ABS-202
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Stock Titan
Earnings call transcript: Absci’s Q1 2026 revenue falls short, stock dips
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Investing.com
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Here is Why Absci Corp. (ABSI) is One of the Best Biotech Penny Stocks to Buy in 2026
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
We Think Absci (NASDAQ:ABSI) Needs To Drive Business Growth Carefully
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Apr 2026 07:00
- Source
- simplywall.st